NCL News Archive

Sunday, May 21, 2017

FIP Pharmaceutical Sciences World Congress; May 21-24, 2017

NCL’s Director, Scott McNeil will be speaking at the 2017 FIP Pharmaceutical Sciences World Congress (PSWC) in Stockholm, Sweden. Additional details will be posted as soon as available.

For more information and to register for the meeting, please visit: http://pswc2017.fip.org/


Thursday, April 6, 2017

International Advanced Drug Delivery Symposium; April 6-7, 2017

The 2017 International Advanced Drug Delivery Symposium (IADDS) will be held in Taipei, Taiwan, April 6-7, 2017. NCL’s Sr. Principal Scientist in Immunology will be speaking. Further details will be posted soon.


Saturday, April 1, 2017

American Association for Cancer Research (AACR) Annual Meeting, April 1-5, 2017

This year’s AACR annual meeting will take place April 1-5, 2017, at the Walter E. Washington Convention Center in Washington, DC. NCL Sr. Scientist Dr. Jennifer Grossman will be speaking at an NCI-sponsored session on “Resources at the Frederick National Lab for Cancer Research”. If you have questions about how the NCL testing program works, what resources are available, or whether or not your technology would be a good fit for NCL, Jennifer will be available to answer questions.

For more information on this year’s AACR meeting, or to register, please visit:
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=105#.WEbZrk00OUk


Monday, March 20, 2017

USP Workshop: Nanomedicines – Technical and Regulatory Perspectives; March 20-22, 2017

The United States Pharmacopeia (USP), along with co-sponsors AAPS and FIP, is hosting a three-day workshop on the technical and regulatory perspectives of nanomedicines. The meeting will be held March 20-22, 2017 in Rockville, MD. The draft agenda has been posted and includes global speakers from industry, academia, various government organizations. NCL’s Director Scott McNeil is slated to speak on day two of meeting and will discuss analytical challenges and advances in nanomedicine characterization.

For more information, please visit: http://www.usp.org/meetings-courses/workshops/nanomedicines-technical-and-regulatory-perspectives


Sunday, March 12, 2017

Society of Toxicology Annual Meeting; March 12-16, 2017

The 2017 SOT Annual Meeting and Tox Expo will be held in Baltimore, MD. Several staff members from the NCL will be attending, including Dr. Stephan Stern, NCL’s Pharmacology & Toxicology Sr. Principal Scientist. Details about NCL talk and poster times will be posted as soon as they’re available.

For more information and to register for the meeting, please visit: http://www.toxicology.org/events/am/AM2017/


Sunday, November 13, 2016

AAPS Annual Meeting; Nov. 13-17, 2016

Dr. Stephan Stern, NCL’s Pharmacology & Toxicology Lead, will be speaking on “NBCD Pharmacokinetics and Bioanalytical Methods to Measure Drug Release”. The talk will be featured in the “Analytical Characterization of Complex Drug Products: Can We Keep Up with Complexity?” session, Wednesday November 16, 9:40 am - 12:00 pm.

For more information and to register for the meeting, please visit: http://www.aaps.org/AMRegister/


Wednesday, November 9, 2016

Equivalence of Complex Drug Products: Scientific and Regulatory Challenges; Nov. 9, 2016

The Non Biological Complex Drugs Working Group, the Nanotechnology Characterization Laboratory (NCL), and the New York Academy of Sciences are co-hosting a conference on the scientific and regulatory challenges associated with evaluating the equivalence of complex drug products. This conference will bring in experts from around the world to discuss approaches for complex drug development and regulation, challenges in the assessment of complex drug equivalence, and differences and commonalities in the behavior of biological and non-biological complex drug families. Speakers include representatives from academia, industry, and regulatory agencies. Abstracts are being accepted for posters, and two abstracts will be selected for inclusion in the oral presentation program.

For more information and to register for the meeting, please visit: http://www.nyas.org/ComplexDrugs16


Monday, October 31, 2016

NCL Lessons Learned Workshop; Oct. 31, 2016

The NCL will be hosting its 8th Lessons Learned Workshop (LLW), October 31, 2016, in Bethesda, Maryland. The LLW is an intensive workshop on the science of preclinical characterization of nanomaterials. This meeting will cover some of the "lessons learned" from the NCL's testing of more than 350 nanotechnology-based candidate cancer treatments and diagnostics.

The half-day session will cover methods for nanomaterial characterization, including strategies for evaluating batch-to-batch consistency, surface characterization, nanomaterial ADME/Tox and PK, sterility and endotoxin contamination, immunotoxicity, and linking physicochemical characterization to safety and efficacy. This session will highlight methods and case studies from the NCL's three-phase Assay Cascade.

For more information and to register for the meeting, please visit: https://ncifrederick.cancer.gov/events/NCL2016/default.asp


Wednesday, October 19, 2016

Applied Pharmaceutical Nanotechnology Meeting; Oct. 19, 2016

NCL’s Dr. Jennifer Grossman will be speaking on the latest capabilities of NCL and collaboration opportunities. She will be available to discuss your specific strategy and ways we might collaborate.

For more information and to register for the meeting, please visit: http://www.bostonsociety.org/APN/


Thursday, February 2, 2017

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

The first issue of ACS Nano for 2017 features an article on the “Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.” The article, co-authored by NCL’s Senior Immunologist, Marina Dobrovolskaia, along with several other well-known names in the field, summarizes the topics of discussion from a recent meeting on the subject. The two-day workshop was held in Brekenridge, Colorado in July 2016 and featured expert speakers from academia and industry, as well as clinicians. Some of the topics summarized include interaction with the complement system, clearance by the MPS, enhancing transport in the stroma, and tumor targeting.

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

Anchordoquy, T.J., Barenholz, Y., Boraschi, D., Chorny, M., Decuzzi, P., Dobrovolskaia, M.A., Farhangrazi, Z.S., Farrell, D., Gabizon, A., Ghandehari, H., Godin, B., La-Beck, N.M., Ljubimova, J., Moghimi, S.M., Pagliaro, L., Park, J.H., Peer, D., Ruoslahti, E., Serkova, N.J., and Simberg, D.

ACS Nano. 2017, 11(1), 12-18.

PMID: 28068099


Pages